发明名称 |
FREMGANGSMÅDER TIL BEHANDLING VED ANVENDELSE AF SELEKTI-VE BCL-2-HÆMMERE |
摘要 |
This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-x L . |
申请公布号 |
DK2642999(T3) |
申请公布日期 |
2017.01.09 |
申请号 |
DK20110793928T |
申请日期 |
2011.11.22 |
申请人 |
AbbVie Ireland Unlimited Company |
发明人 |
ELMORE, Steven;SOUERS, Andrew;WANG, Li Chun;GHAYUR, Tariq;PERPER, Stuart J. |
分类号 |
A61K31/496;A61P37/00 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|